These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

492 related items for PubMed ID: 8857482

  • 1. Effects of carvedilol on systolic and diastolic left ventricular performance in idiopathic dilated cardiomyopathy or ischemic cardiomyopathy.
    Quaife RA, Gilbert EM, Christian PE, Datz FL, Mealey PC, Volkman K, Olsen SL, Bristow MR.
    Am J Cardiol; 1996 Oct 01; 78(7):779-84. PubMed ID: 8857482
    [Abstract] [Full Text] [Related]

  • 2. Effects of carvedilol therapy on restrictive diastolic filling pattern in chronic heart failure.
    Palazzuoli A, Carrera A, Calabria P, Puccetti L, Pastrorelli M, Pasqui AL, Auteri A, Bruni F.
    Am Heart J; 2004 Jan 01; 147(1):E2. PubMed ID: 14691440
    [Abstract] [Full Text] [Related]

  • 3. Beta-blockade therapy in chronic heart failure: diastolic function and mitral regurgitation improvement by carvedilol.
    Capomolla S, Febo O, Gnemmi M, Riccardi G, Opasich C, Caporotondi A, Mortara A, Pinna GD, Cobelli F.
    Am Heart J; 2000 Apr 01; 139(4):596-608. PubMed ID: 10740140
    [Abstract] [Full Text] [Related]

  • 4. An echocardiographic analysis of the long-term effects of carvedilol on left ventricular remodeling, systolic performance, and ventricular filling patterns in dilated cardiomyopathy.
    Rahko PS.
    Echocardiography; 2005 Aug 01; 22(7):547-54. PubMed ID: 16060890
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. A controlled study of the effects of carvedilol on clinical events, left ventricular function and proinflammatory cytokines levels in patients with dilated cardiomyopathy.
    Tatli E, Kurum T.
    Can J Cardiol; 2005 Mar 15; 21(4):344-8. PubMed ID: 15838561
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Dilated cardiomyopathy in dialysis patients--beneficial effects of carvedilol: a double-blind, placebo-controlled trial.
    Cice G, Ferrara L, Di Benedetto A, Russo PE, Marinelli G, Pavese F, Iacono A.
    J Am Coll Cardiol; 2001 Feb 15; 37(2):407-11. PubMed ID: 11216954
    [Abstract] [Full Text] [Related]

  • 9. Left ventricular remodeling with carvedilol in patients with congestive heart failure due to ischemic heart disease. Australia-New Zealand Heart Failure Research Collaborative Group.
    Doughty RN, Whalley GA, Gamble G, MacMahon S, Sharpe N.
    J Am Coll Cardiol; 1997 Apr 15; 29(5):1060-6. PubMed ID: 9120160
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Carvedilol improves left atrial and left ventricular function and reserve in dilated cardiomyopathy after 1 year of treatment.
    Paraskevaidis I, Farmakis D, Parissis JT, Dodouras T, Filippatos G, Tsiapras D, Kremastinos DT.
    J Card Fail; 2007 Mar 15; 13(2):108-13. PubMed ID: 17395050
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Effects of short- and long-term carvedilol administration on rest and exercise hemodynamic variables, exercise capacity and clinical conditions in patients with idiopathic dilated cardiomyopathy.
    Metra M, Nardi M, Giubbini R, Dei Cas L.
    J Am Coll Cardiol; 1994 Dec 15; 24(7):1678-87. PubMed ID: 7963115
    [Abstract] [Full Text] [Related]

  • 14. Effects of carvedilol on systolic and diastolic left ventricular performance in idiopathic dilated cardiomyopathy or ischemic cardiomyopathy.
    Lee YC.
    Am J Cardiol; 1997 Apr 01; 79(7):1001. PubMed ID: 9104927
    [No Abstract] [Full Text] [Related]

  • 15. Carvedilol improves left ventricular function and symptoms in chronic heart failure: a double-blind randomized study.
    Olsen SL, Gilbert EM, Renlund DG, Taylor DO, Yanowitz FD, Bristow MR.
    J Am Coll Cardiol; 1995 May 01; 25(6):1225-31. PubMed ID: 7722114
    [Abstract] [Full Text] [Related]

  • 16. [The effects of mid- and long-term administration (3-4 years) of carvedilol in patients with idiopathic dilated cardiomyopathy].
    Metra M, Nodari S, Garbellini M, Boldi E, Rosselli F, Milan E, Giubbini R, Dei Cas L.
    Cardiologia; 1997 May 01; 42(5):503-12. PubMed ID: 9289367
    [Abstract] [Full Text] [Related]

  • 17. Randomised, placebo-controlled trial of carvedilol in patients with congestive heart failure due to ischaemic heart disease. Australia/New Zealand Heart Failure Research Collaborative Group.
    Lancet; 1997 Feb 08; 349(9049):375-80. PubMed ID: 9033462
    [Abstract] [Full Text] [Related]

  • 18. Effects of carvedilol on plasma levels of pro-inflammatory cytokines in patients with ischemic and nonischemic dilated cardiomyopathy.
    Kurum T, Tatli E, Yuksel M.
    Tex Heart Inst J; 2007 Feb 08; 34(1):52-9. PubMed ID: 17420794
    [Abstract] [Full Text] [Related]

  • 19. Effect of carvedilol on diastolic function in patients with diastolic heart failure and preserved systolic function. Results of the Swedish Doppler-echocardiographic study (SWEDIC).
    Bergström A, Andersson B, Edner M, Nylander E, Persson H, Dahlström U.
    Eur J Heart Fail; 2004 Jun 08; 6(4):453-61. PubMed ID: 15182771
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 25.